Leonurine hydrochloride

CAS No. 24735-18-0

Leonurine hydrochloride( SCM-198 hydrochloride )

Catalog No. M17452 CAS No. 24735-18-0

Leonurine (hydrochloride), a major alkaloid compound extracted from Leonurus japonicas Houtt. (Labiatae), is considered to have antitumor roles.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 47 Get Quote
10MG 71 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Leonurine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Leonurine (hydrochloride), a major alkaloid compound extracted from Leonurus japonicas Houtt. (Labiatae), is considered to have antitumor roles.
  • Description
    Leonurine (hydrochloride), a major alkaloid compound extracted from Leonurus japonicas Houtt. (Labiatae), is considered to have antitumor roles.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SCM-198 hydrochloride
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    TLR
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    24735-18-0
  • Formula Weight
    347.79
  • Molecular Formula
    C14H22ClN3O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 31 mg/mL; 89.13 mM
  • SMILES
    COc1cc(cc(c1O)OC)C(=O)OCCCCNC(=N)N.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mao F, et al. Leonurine hydrochloride induces apoptosis of H292 lung cancer cell by a mitochondria-dependent pathway. Pharm Biol. 2015;53(11):1684-90.
molnova catalog
related products
  • A-935142

    A-935142 is a human ether-a-go-go-related gene (hERG, Kv 11.1) channel activator that enhances hERG currents by slowing inactivation, promoting activation, reducing inactivation, and shortening atrial and ventricular repolarization in a complex manner.

  • Matuzumab

    Matuzumab is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR frequently associated with the growth of blood vessels in malignancy facilitating tumor growth and survival.

  • Befotertinib

    Befotertinib is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cell lung cancer.